therrnophilus < these < theself

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by these

Number of relevant bibliographic references: 2393.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000002 (2020)	Jing Xu [République populaire de Chine] ; Han Zhang [République populaire de Chine] ; Jinfang Zheng [États-Unis] ; Philippe Dovoedo [États-Unis] ; Yanbin Yin [États-Unis]	eCAMI: simultaneous classification and motif identification for enzyme annotation.
000007 (2020)	Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine]	[Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)].
000008 (2020)	H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine]	[Potential antiviral therapeutics for 2019 Novel Coronavirus].
000010 (2020)	Peter Kranke ; Stephanie Weibel ; Magdalena Sitter ; Patrick Meybohm ; Thierry Girard	[Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees].
000028 (2020)	Jennifer Cable [États-Unis] ; Padmini Srikantiah [États-Unis] ; James E. Crowe [États-Unis] ; Bali Pulendran [États-Unis] ; Adrian Hill [Royaume-Uni] ; Ann Ginsberg [États-Unis] ; Wayne Koff [États-Unis] ; Anuja Mathew [États-Unis] ; Tony Ng [États-Unis] ; Kathrin Jansen [États-Unis] ; Gregory Glenn [États-Unis] ; Sallie Permar [États-Unis] ; Ian Wilson [États-Unis] ; David B. Weiner [États-Unis] ; Drew Weissman [États-Unis] ; Rino Rappuoli [Royaume-Uni]	Vaccine innovations for emerging infectious diseases-a symposium report.
000033 (2020)	Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France]	Type 1 interferons as a potential treatment against COVID-19
000034 (2020)	Vineet D. Menachery [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Boyd L. Yount [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Andrew Hale [États-Unis] ; Rachel L. Graham [États-Unis] ; Trevor Scobey [États-Unis] ; Simon J. Anthony [États-Unis] ; Lingshu Wang [États-Unis] ; Barney Graham [États-Unis] ; Scott H. Randell [États-Unis] ; W Ian Lipkin [États-Unis] ; Ralph S. Baric [États-Unis]	Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.
000043 (2020)	Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan]	The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
000050 (2020)	Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis]	The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
000051 (2020)	Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada]	The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
000052 (2020)	S Nia Garcia [Espagne] ; Jonathan F. Wendel [États-Unis] ; Natalia Borowska-Zuchowska [Pologne] ; Malika Aïnouche [France] ; Alena Kuderova ; Ales Kovarik	The Utility of Graph Clustering of 5S Ribosomal DNA Homoeologs in Plant Allopolyploids, Homoploid Hybrids, and Cryptic Introgressants
000059 (2020)		The Impact and Control of Emerging and Re-Emerging Viral Diseases in the Environment: An African Perspective
000061 (2020)	Sang-Hwa Oh ; Seo Yoon Lee ; Changhyun Han	The Effects of Social Media Use on Preventive Behaviors during Infectious Disease Outbreaks: The Mediating Role of Self-relevant Emotions and Public Risk Perception.
000062 (2020)	Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine]	The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
000066 (2020)	Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine]	Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
000071 (2020)	Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis]	Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
000073 (2020)	Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan]	Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
000077 (2020)	Isabel Ortiz De Solorzano [Espagne] ; Karteek K. Bejagam ; Yaxin An ; Samrendra K. Singh ; Sanket A. Deshmukh	Solvation dynamics of N-substituted acrylamide polymers and the importance for phase transition behavior.
000082 (2020)	Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie]	Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
000090 (2020)	Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie]	Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity
000095 (2020)	Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada]	Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "these" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "these" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    these
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021